Margaret has over 25 years of Regulatory Affairs experience covering all stages of development for drugs, biologics, cell and gene therapies, and combination products. Prior to joining InCarda, Margaret held regulatory leadership roles in several Bay Area companies – BioInspire Technologies, Cellerant Therapeutics, CV Therapeutics, SyStemix and Connetics. Her experience includes regulatory development and approvals for new chemical and biological entities as well as for new uses of previously-approved active ingredients across a variety of therapeutic fields – cardiovascular medicines, dermatology, allergic conditions, oncology and rheumatology.
Margaret holds a B.S. in Chemistry from the State University of New York at Albany and a Ph.D. in Biochemical Pharmacology from the State University of New York at Buffalo, with additional post-doctoral research training in cell and molecular biology.